brain tumor Seizures
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria for glioma patients: (1) adult (> 18 years) (2) epilepsy (at least one epileptic seizure) (3) histopathologically confirmed glioma or meningioma according to the WHO (4) written informed consent.;Inclusion criteria for healthy controls (1) adult (> 18 years) (2) written informed consent;Inclusion criteria for language side-study (amendment): (1) received intraoperative language mapping (2) received resective brain surgery in the dominant hemisphere (3) Dutch is native language
Exclusion criteria
Exclusion criteria: Exclusion criteria for glioma patients: (1) psychiatric disease or symptoms (2) insufficient mastery of the Dutch language (3) inability to communicate adequately;Exclusion criteria for healthy controls: (1) use of centrally acting drugs (including analgetics) (2) psychiatric disease or symptoms (3) disorders of the central nervous system (4) insufficient mastery of the Dutch language
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| cognition Language-study The secondary study parameters are the neuropsychological tests obtained pre- and postoperatively by a neuropsychologist. | — |
Primary
| Measure | Time frame |
|---|---|
| - MEG-measures: clustercoefficient padlength synchronisation likelihood - epilepsy diary (frequency and severity) and epilepsy burden Language-study The main study parameters are an extensive language task, a naming task and a language performance questionnaire assessing functional outcome in patients who received resective brain surgery after intraoperative language mapping. The language task will measure language performance in various domains, e.g. speaking, listening, reading and writing, whereas the questionnaire will obtain information on how patients perceive their own language performance. The naming task will measure performance pre and post operatively. | — |
Countries
Netherlands